Register or sign in to continue.
Tim Craig

Tim Craig

Jul 11, 2014

Group 6 Copy 54
1

Why are proteins important?

http://en.wikipedia.org/wiki/Protein_expression_(b...

  1. High Yield - x-ray crystallographers like me need large quantities of protein, 100s of milligrams.
  2. Low cost - E.coli is cheap, mammalian is expensive.
  3. Post-translational Modifications - E.coli doesn't have these, which can be critical for the folding of human proteins.

http://www.google.com/patents/US6589783 European Molecular Biology Laboratory Expression System Overview from Life Technologies A PLOS One article involving expression scouting of integral membrane proteins

1 comment

Join the conversation!Sign In
  • William Sharpe
    William SharpeBacker
    Could you take a guess at the proportion of the cost of developing new medicines that is made up of expensive IP licenses like the one you mentioned here?
    Jul 12, 2014
  • Tim Craig
    Tim CraigResearcher
    It's not a major driver of the total cost of developing a new medicine, which is on the order of a billion USD. However, these types of licensing agreements can become major obstacles for startup biotechs, startup service businesses (contract research labs that do lab work for other customers), and small cap pharma. Typically patent holders in this area will ask for recurring payments of between $5,000-20,000 annually and royalties of between 5 and 10% on anything the technology was used for. It doesn't seem like much, but if you had to start paying 6 or 7 of those you'd already have quite a bill to settle just to open your doors. This is on top of the already massive costs of starting a biotech (especially compared to tech) due to the requirements of owning or renting very expensive and sensitive laboratory equipment. In addition to the pure cash aspect of drug discovery, there's the issue of time. New drugs take around 10-15 years to develop, 3-6 of those years will be spent in what is called "Drug Discovery", which is the area the vector here would be used in. Check out chapter 4, page 32 for an overview here: http://www.phrma.org/sites/default/files/pdf/PhRMA%20Profile%202013.pdf If a multisystem vector was used during the early stages of DD, I could see it being possible to shave 6 months to a year off of the drug discovery timeline. It would also provide a way to rescue many of the early projects that end up being cancelled due to inability to make the target protein. This last aspect is really important, because there is a serious lack of new targets in drug discovery. Part of the reason for this is risk management, but the other part is that when scientists(in industry) propose new targets, they often only have a few months to demonstrate that the target is viable. These few months can easily be eaten up in protein expression and purification testing.
    Jul 13, 2014

About This Project

TimPharma LLC
I'd like to make an IP-free expression vector for recombinant proteins to enable protein expression in 4 expression hosts with a single vector. This will make the expression of recombinant proteins for drug research easier, faster, and cheaper!

Results will be published with data in an open access, peer reviewed journal. In the end the new expression plasmid will be submitted to Addgene and DNASU, which will enable users all over the world.

More Lab Notes From This Project

Blast off!

Browse Other Projects on Experiment

Related Projects

Urban Pollination: sustain native bees & urban crops

Bee activity on our crop flowers is crucial to human food security, but bees are also declining around the...

Cannibalism in Giant Tyrannosaurs

This is the key question we hope to answer with this study. This project is to fund research into a skull...

Seattle HiveBio Community Lab

Thank you to everyone who has supported HiveBio thus far. As of April 17th we've reached our basic funding...

Campaign Ended

A biology project funded by 9 people

Add a comment